<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD08750000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P52565</UniProt_ID>
  <Seq_Length>204</Seq_Length>
  <Molecule_Weight>23207</Molecule_Weight>
  <KEGG_ID>hsa:396</KEGG_ID>
  <Orthology_ID>K12462</Orthology_ID>
  <Function_Summary>Regulates the GDP/GTP exchange reaction of the Rho proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP to them (By similarity).</Function_Summary>
  <Pfam_ID>PF02115:Rho_GDI</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Rho-GDI alpha</Alias>
      <Alias>Rho GDI 1</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Increases the activity of a GTPase, an enzyme that catalyzes the hydrolysis of GTP.</Detail>
      <Keyword>GTPase activator activity</Keyword>
      <Ontology_ID>GO:0005096</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Prevents the dissociation of GDP from the small GTPase Rho, thereby preventing GTP from binding.</Detail>
      <Keyword>Rho GDP-dissociation inhibitor activity</Keyword>
      <Ontology_ID>GO:0005094</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The directed, self-propelled movement of a cellular component without the involvement of an external agent such as a transporter or a pore.</Detail>
      <Keyword>Cellular component movement</Keyword>
      <Ontology_ID>GO:0006928</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process which directly inhibits any of the steps required for cell death by apoptosis.</Detail>
      <Keyword>Anti-apoptosis</Keyword>
      <Ontology_ID>GO:0006916</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of cell adhesion.</Detail>
      <Keyword>Negative regulation of cell adhesion</Keyword>
      <Ontology_ID>GO:0007162</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of axonogenesis.</Detail>
      <Keyword>Positive regulation of axonogenesis</Keyword>
      <Ontology_ID>GO:0050772</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of the nerve growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Nerve growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0048011</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of small GTPase mediated signal transduction.</Detail>
      <Keyword>Regulation of small GTPase mediated signal transduction</Keyword>
      <Ontology_ID>GO:0051056</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of axonogenesis.</Detail>
      <Keyword>Negative regulation of axonogenesis</Keyword>
      <Ontology_ID>GO:0050771</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of molecular signals within the cell that are mediated by a member of the Rho family of proteins switching to a GTP-bound active state.</Detail>
      <Keyword>Rho protein signal transduction</Keyword>
      <Ontology_ID>GO:0007266</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>127</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>141</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>2</Position>
      <PTM_Type>N-acetylalanine</PTM_Type>
    </PTM>
    <PTM>
      <Position>178</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>105</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MAEQEPTAEQLAQIAAENEEDEHSVNYKPPAQKSIQEIQELDKDDESLRKYKEALLGRVAVSADPNVPNVVVTGLTLVCSSAPGPLELDLTGDLESFKKQSFVLKEGVEYRIKISFRVNREIVSGMKYIQHTYRKGVKIDKTDYMVGSYGPRAEEYEFLTPVEEAPKGMLARGSYSIKSRFTDDDKTDHLSWEWNLTIKKDWKD</Protein_Seq>
    <DNA_Seq>GGCAGCCGCGGTCCATCGCGTTCGGGGGCGACGCGGGGATTGGGGCGCGGCCTCCCCCAGCGCCCGGGCCACGCCCGGCACGGATTGCGGGCCCTGCGGAAGTGCGGGCCGCGCCCTAGGATCCCGGCGCCTACGGCTATCCTCGCGCGGCGCGGAGGCCCCAGCCCCTGGAGGAAGCAGGGCGGCCTGGACCCCGGCCTGGGTGTCCCGGGTGTGCTGCTCCCTGACCCACCTCCCACGCTGCCGGGAAGGATCTGAGCCTGACAGATCCCCTGCCGGGTGTCCCGACCCAGGCTAAGCTTGAGCATGGCTGAGCAGGAGCCCACAGCCGAGCAGCTGGCCCAGATTGCAGCGGAGAACGAGGAGGATGAGCACTCGGTCAACTACAAGCCCCCGGCCCAGAAGAGCATCCAGGAGATCCAGGAGCTGGACAAGGACGACGAGAGCCTGCGAAAGTACAAGGAGGCCCTGCTGGGCCGCGTGGCCGTTTCCGCAGACCCCAACGTCCCCAACGTCGTGGTGACTGGCCTGACCCTGGTGTGCAGCTCGGCCCCGGGCCCCCTGGAGCTGGACCTGACGGGCGACCTGGAGAGCTTCAAGAAGCAGTCGTTTGTGCTGAAGGAGGGTGTGGAGTACCGGATAAAAATCTCTTTCCGGGTTAACCGAGAGATAGTGTCCGGCATGAAGTACATCCAGCATACGTACAGGAAAGGCGTCAAGATTGACAAGACTGACTACATGGTAGGCAGCTATGGGCCCCGGGCCGAGGAGTACGAGTTCCTGACCCCCGTGGAGGAGGCACCCAAGGGTATGCTGGCCCGGGGCAGCTACAGCATCAAGTCCCGCTTCACAGACGACGACAAGACCGACCACCTGTCCTGGGAGTGGAATCTCACCATCAAGAAGGACTGGAAGGACTGAGCCCAGCCAGAGGCGGGCAGGGCAGACTGACGGACGGACGACGGACAGGCGGATGTGTCCCCCCCAGCCCCTCCCCTCCCCATACCAAAGTGCTGACAGGCCCTCCGTGCCCCTCCCACCCTGGTCCGCCTCCCTGGCCTGGCTCAACCGAGTGCCTCCGACCCCCCTCCTCAGCCCTCCCCCACCCACAGGCCCAGCCTCCTCGGTCTCCTGTCTCGTTGCTGCTTCTGCCTGTGCTGTGGGGGAGAGAGGCCGCAGCCAGGCCTCTGCTGCCCTTTCTGTGCCCCCCAGGTTCTATCTCCCCGTCACACCCGAGGCCTGGCTTCAGGAGGGAGCGGAGCAGCCATTCTCCAGGCCCCGTGGTTGCCCCTGGACGTGTGCGTCTGCTGCTCCGGGGTGGAGCTGGGGTGTGGGATGCACGGCCTCGTGGGGGCCGGGCCGTCCTCCAGCCCCGCTGCTCCCTGGCCAGCCCCCTTGTCGCTGTCGGTCCCGTCTAACCATGATGCCTTAACATGTGGAGTGTACCGTGGGGCCTCACTAGCCTCTAACTCCCTGTGTCTGCATGAGCATGTGGCCTCCCCGTCCCTTCCCCGGTGGCGAACCCAGTGACCCAGGGACACGTGGGGTGTGCTGCTGCTGCTCCCCAGCCCACCAGTGCCTGGCCAGCCTGCCCCCTTCCCTGGACAGGGCTGTGGAGATGGCTCCGGCGGCTTGGGGAAAGCCAAATTGCCAAAACTCAAGTCACCTCAGTACCATCCAGGAGGCTGGGTATTGTCCTGCCTCTGCCTTTTCTGTCTCAGCGGGCAGTGCCCAGAGCCCACACCCCCCCAAGAGCCCTCGATGGACAGCCTCACCCACCCCACCTGGGCCCAGCCAGGAGCCCCGCCTGGCCATCAGTATTTATTGCCTCCGTCCGTGCCGTCCCTGGGCCACTGGCCTGGCGCCTGTTCCCCCAGGCTCTCAGTGCCACCACCCCCGGCAGGCCTTCCCTGACCCAGCCAGGAACAAACAAGGGACCAAGTGCACACATTGCTGAGAGCCGTCTCCTGTGCCTCCCCCGCCCCATCCCCGGTCTTCGTGTTGTGTCTGCCAGGCTCAGGCAGAGGCGCCTGTCCCTGCTTCTTTTCTGACCGGGAAATAAATGCCCCTGAAGGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoskeleton</CellLocal>
      <Ontology_ID>GO:0005856</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>ARHGDIA</Gene_Name>
    <Gene_Alias>GDIA1</Gene_Alias>
    <Gene_ID>396</Gene_ID>
    <Genbank_ACCN>NM_001185077</Genbank_ACCN>
    <Protein_ACCN>NP_001172006</Protein_ACCN>
    <HGNC_ID>678</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/396</Gene_URL>
    <UCSC_ID>uc002kbq.3</UCSC_ID>
    <EMBL_ID>ENSG00000141522</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Nephrotic Syndrome Type 3</Disease_Name>
      <Disease_Detail>Nephrotic Syndrome</Disease_Detail>
      <Disease_DB>NPH038</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nephrotic_syndrome_type_3?search=ARHGDIA#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nephrotic Syndrome</Disease_Name>
      <Disease_Detail>Nephrotic Syndrome</Disease_Detail>
      <Disease_DB>NPH012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nephrotic_syndrome?search=ARHGDIA#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nephrotic Syndrome, Type 8</Disease_Name>
      <Disease_Detail>Nephrotic Syndrome</Disease_Detail>
      <Disease_DB>NPH073</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nephrotic_syndrome_type_8?search=ARHGDIA#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Familial Idiopathic Steroid-Resistant Nephrotic Syndrome with Diffuse Mesangial Sclerosis</Disease_Name>
      <Disease_Detail>Familial Idiopathic Steroid-Resistant Nephrotic Syndrome with Diffuse Mesangial Sclerosis</Disease_Detail>
      <Disease_DB>FML267</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/familial_idiopathic_steroid_resistant_nephrotic_syndrome_with_diffuse_mesangial_sclerosis?search=ARHGDIA#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal structure of RhoGDI Glu(154,155)Ala mutant</PDB_Title>
      <PDB_ID>1KMT</PDB_ID>
      <Resolution>1.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1KMT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The impact of Glu--&gt;Ala and Glu--&gt;Asp mutations on the crystallization properties of RhoGDI: the structure of RhoGDI at 1.3 A resolution.</PubMed_Title>
      <Author>Mateja, A., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2002)58:1983-1991</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12454455?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>RAC1-RHOGDI COMPLEX INVOLVED IN NADPH OXIDASE ACTIVATION</PDB_Title>
      <PDB_ID>1HH4</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HH4</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure of the Rac1-Rhogdi Complex Involved in Nadph Oxidase Activation</PubMed_Title>
      <Author>Grizot, S., et al.</Author>
      <Journal>Biochemistry(2001)40:10007</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11513578?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF RHOGDI Lys(135,138,141)Tyr MUTANT</PDB_Title>
      <PDB_ID>2BXW</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2BXW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Protein Crystallization by Surface Entropy Reduction: Optimization of the Ser Strategy</PubMed_Title>
      <Author>Cooper, D.R., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2007)63:636</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17452789?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF RHOGDI E155S, E157S MUTANT</PDB_Title>
      <PDB_ID>2JHZ</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2JHZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Protein Crystallization by Surface Entropy Reduction: Optimization of the Ser Strategy</PubMed_Title>
      <Author>Cooper, D.R., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2007)63:636</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17452789?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF RHOGDI E154A,E155A MUTANT</PDB_Title>
      <PDB_ID>2JHU</PDB_ID>
      <Resolution>1.65</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2JHU</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Protein Crystallization by Surface Entropy Reduction: Optimization of the Ser Strategy</PubMed_Title>
      <Author>Cooper, D.R., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2007)63:636</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17452789?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF RHOGDI K138Y, K141Y MUTANT</PDB_Title>
      <PDB_ID>2JI0</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2JI0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Protein Crystallization by Surface Entropy Reduction: Optimization of the Ser Strategy</PubMed_Title>
      <Author>Cooper, D.R., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2007)63:636</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17452789?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF RHOGDI E155H, E157H MUTANT</PDB_Title>
      <PDB_ID>2JHX</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2JHX</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Protein Crystallization by Surface Entropy Reduction: Optimization of the Ser Strategy</PubMed_Title>
      <Author>Cooper, D.R., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2007)63:636</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17452789?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF TRUNCATED HUMAN RHOGDI QUADRUPLE MUTANT</PDB_Title>
      <PDB_ID>1FSO</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FSO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Protein crystallization by rational mutagenesis of surface residues: Lys to Ala mutations promote crystallization of RhoGDI.</PubMed_Title>
      <Author>Longenecker, K.L., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2001)57:679-688</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11320308?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF RHOGDI E154A,E155A MUTANT</PDB_Title>
      <PDB_ID>2JHV</PDB_ID>
      <Resolution>2.07</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2JHV</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Protein Crystallization by Surface Entropy Reduction: Optimization of the Ser Strategy</PubMed_Title>
      <Author>Cooper, D.R., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2007)63:636</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17452789?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF TRUNCATED HUMAN RHOGDI K113A MUTANT</PDB_Title>
      <PDB_ID>1FT0</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FT0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Protein crystallization by rational mutagenesis of surface residues: Lys to Ala mutations promote crystallization of RhoGDI.</PubMed_Title>
      <Author>Longenecker, K.L., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2001)57:679-688</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11320308?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF TRUNCATED HUMAN RHOGDI TRIPLE MUTANT</PDB_Title>
      <PDB_ID>1FST</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FST</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Protein crystallization by rational mutagenesis of surface residues: Lys to Ala mutations promote crystallization of RhoGDI.</PubMed_Title>
      <Author>Longenecker, K.L., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2001)57:679-688</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11320308?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of RhoGDI K(199,200)R double mutant</PDB_Title>
      <PDB_ID>1QVY</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1QVY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The impact of Lys--&gt;Arg surface mutations on the crystallization of the globular domain of RhoGDI.</PubMed_Title>
      <Author>Czepas, J., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2004)60:275-280</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/14747703?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR</PDB_Title>
      <PDB_ID>1RHO</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1RHO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A modulator of rho family G proteins, rhoGDI, binds these G proteins via an immunoglobulin-like domain and a flexible N-terminal arm.</PubMed_Title>
      <Author>Keep, N.H., et al.</Author>
      <Journal>Structure(1997)5:623-633</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9195882?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF RHOGDI K135T,K138T,K141T MUTANT</PDB_Title>
      <PDB_ID>2JHT</PDB_ID>
      <Resolution>1.88</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2JHT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Protein Crystallization by Surface Entropy Reduction: Optimization of the Ser Strategy</PubMed_Title>
      <Author>Cooper, D.R., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2007)63:636</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17452789?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF RHOGDI E155A, E157A MUTANT</PDB_Title>
      <PDB_ID>2JHW</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2JHW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Protein Crystallization by Surface Entropy Reduction: Optimization of the Ser Strategy</PubMed_Title>
      <Author>Cooper, D.R., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2007)63:636</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17452789?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE RHOA.GDP-RHOGDI COMPLEX</PDB_Title>
      <PDB_ID>1CC0</PDB_ID>
      <Resolution>5.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1CC0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>How RhoGDI binds Rho.</PubMed_Title>
      <Author>Longenecker, K., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(1999)55:1503-1515</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10489445?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF RHOGDI E155H, E157H MUTANT</PDB_Title>
      <PDB_ID>2JHY</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2JHY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Protein Crystallization by Surface Entropy Reduction: Optimization of the Ser Strategy</PubMed_Title>
      <Author>Cooper, D.R., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2007)63:636</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17452789?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF TRUNCATED RHOGDI K141A MUTANT</PDB_Title>
      <PDB_ID>1FT3</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FT3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Protein crystallization by rational mutagenesis of surface residues: Lys to Ala mutations promote crystallization of RhoGDI.</PubMed_Title>
      <Author>Longenecker, K.L., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2001)57:679-688</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11320308?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF RHOGDI K135H,K138H,K141H MUTANT</PDB_Title>
      <PDB_ID>2JHS</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2JHS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Protein Crystallization by Surface Entropy Reduction: Optimization of the Ser Strategy</PubMed_Title>
      <Author>Cooper, D.R., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2007)63:636</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17452789?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04962</Pathway_ID>
      <Pathway_Title>Vasopressin-regulated water reabsorption</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Excretory system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04722</Pathway_ID>
      <Pathway_Title>Neurotrophin signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a/b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.fb.b.bb.bi.html</SCOP_URL>
  </Fold>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>